- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- July 2024
- 100 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- December 2021
- 209 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- February 2026
- 50 Pages
Global
From €2321EUR$2,650USD£2,014GBP
Xenon-133 is a radioactive isotope of xenon used in Nuclear Medicine and Radiopharmacology. It is used in a variety of medical imaging procedures, such as lung ventilation/perfusion scans, brain scans, and cardiac imaging. It is also used to measure regional cerebral blood flow and to diagnose pulmonary embolism. Xenon-133 is produced in nuclear reactors and is available in a variety of forms, including gas, liquid, and solid.
The Xenon-133 market is composed of a variety of companies, including GE Healthcare, Mallinckrodt Pharmaceuticals, and Nordion. These companies provide Xenon-133 for medical imaging and research purposes. Additionally, there are a number of companies that specialize in the production and distribution of Xenon-133, such as Isotron, Isotope Technologies, and Isotope Products International. Show Less Read more